ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q4 2025 Earnings Call Transcript February 27, 2026
ALX Oncology Holdings Inc. misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.38.
Operator: Greetings, and welcome to the ALX Oncology Holdings Inc. Fourth Quarter 2025 Financial Results Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being...
